These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 17080429)

  • 21. [Coenzyme q10 in childhood: detection methods, reference values and disease-related changes in the coenzyme q10 status].
    Menke T
    Georgian Med News; 2008 Mar; (156):24-32. PubMed ID: 18403806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reducing exercise-induced muscular injury in kendo athletes with supplementation of coenzyme Q10.
    Kon M; Tanabe K; Akimoto T; Kimura F; Tanimura Y; Shimizu K; Okamoto T; Kono I
    Br J Nutr; 2008 Oct; 100(4):903-9. PubMed ID: 18284711
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Review of clinical trials for mitochondrial disorders: 1997-2012.
    Kerr DS
    Neurotherapeutics; 2013 Apr; 10(2):307-19. PubMed ID: 23361264
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial dysfunction in mitochondrial diabetes treated with Coenzyme Q10.
    Salles JE; Moisés VA; Almeida DR; Chacra AR; Moisés RS
    Diabetes Res Clin Pract; 2006 Apr; 72(1):100-3. PubMed ID: 16253379
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot clinical trial of the effects of coenzyme Q10 on chronic tinnitus aurium.
    Khan M; Gross J; Haupt H; Jainz A; Niklowitz P; Scherer H; Schmidt FP; Klapp BF; Reisshauer A; Mazurek B
    Otolaryngol Head Neck Surg; 2007 Jan; 136(1):72-7. PubMed ID: 17210337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-lipoic acid treatment of 31 patients with sore, burning mouth.
    Steele JC; Bruce AJ; Drage LA; Rogers RS
    Oral Dis; 2008 Sep; 14(6):529-32. PubMed ID: 18266840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coenzyme Q(10): a novel therapeutic approach for Fibromyalgia? case series with 5 patients.
    Cordero MD; Alcocer-Gómez E; de Miguel M; Cano-García FJ; Luque CM; Fernández-Riejo P; Fernández AM; Sánchez-Alcazar JA
    Mitochondrion; 2011 Jul; 11(4):623-5. PubMed ID: 21496502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Two patients with mitochondrial respiratory chain disease].
    Bangma HR; Smit GP; Kuks JB; Grevink RG; Wolffenbuttel BH
    Ned Tijdschr Geneeskd; 2008 Oct; 152(42):2298-301. PubMed ID: 19009881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of differing protein sources and a creatine containing nutritional formula after 12 weeks of resistance training.
    Kerksick CM; Rasmussen C; Lancaster S; Starks M; Smith P; Melton C; Greenwood M; Almada A; Kreider R
    Nutrition; 2007 Sep; 23(9):647-56. PubMed ID: 17679046
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The antioxidant alpha-lipoic acid improves endothelial dysfunction induced by acute hyperglycaemia during OGTT in impaired glucose tolerance.
    Xiang GD; Sun HL; Zhao LS; Hou J; Yue L; Xu L
    Clin Endocrinol (Oxf); 2008 May; 68(5):716-23. PubMed ID: 18070144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coenzyme Q(10) and alpha-lipoic acid supplementation in diabetic rats: conduction velocity distributions.
    Ayaz M; Tuncer S; Okudan N; Gokbel H
    Methods Find Exp Clin Pharmacol; 2008 Jun; 30(5):367-74. PubMed ID: 18806896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A case of mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes (MELAS)--treatment with coenzyme Q10 and idebenone].
    Ihara Y; Namba R; Kuroda S
    Rinsho Shinkeigaku; 1988 Jan; 28(1):62-6. PubMed ID: 3383514
    [No Abstract]   [Full Text] [Related]  

  • 33. Targeting cellular energy production in neurological disorders.
    Baker SK; Tarnopolsky MA
    Expert Opin Investig Drugs; 2003 Oct; 12(10):1655-79. PubMed ID: 14519086
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders.
    Tarnopolsky MA; Beal MF
    Ann Neurol; 2001 May; 49(5):561-74. PubMed ID: 11357946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial.
    Dell'Anna ML; Mastrofrancesco A; Sala R; Venturini M; Ottaviani M; Vidolin AP; Leone G; Calzavara PG; Westerhof W; Picardo M
    Clin Exp Dermatol; 2007 Nov; 32(6):631-6. PubMed ID: 17953631
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs.
    Brenner SR
    Neurology; 2010 Jan; 74(2):182-3; author reply 183. PubMed ID: 20065258
    [No Abstract]   [Full Text] [Related]  

  • 37. Creatine monohydrate enhances strength and body composition in Duchenne muscular dystrophy.
    Tarnopolsky MA; Mahoney DJ; Vajsar J; Rodriguez C; Doherty TJ; Roy BD; Biggar D
    Neurology; 2004 May; 62(10):1771-7. PubMed ID: 15159476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burning Mouth Syndrome: open trial of psychotherapy alone, medication with alpha-lipoic acid (thioctic acid), and combination therapy.
    Femiano F; Gombos F; Scully C
    Med Oral; 2004; 9(1):8-13. PubMed ID: 14704612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.
    Young JM; Florkowski CM; Molyneux SL; McEwan RG; Frampton CM; George PM; Scott RS
    Am J Cardiol; 2007 Nov; 100(9):1400-3. PubMed ID: 17950797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Burning mouth syndrome: the efficacy of lipoic acid on subgroups.
    Femiano F; Gombos F; Scully C
    J Eur Acad Dermatol Venereol; 2004 Nov; 18(6):676-8. PubMed ID: 15482293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.